CL2015000442A1 - Compounds derived from spirocyclic acylguanidines, inhibitors of the activity of the beta-secretase enzyme (bace1); intermediary compounds; pharmaceutical composition; and use to treat a disorder or disease selected from Alzheimer's, trisomy 21 (down syndrome), senile dementia, parkinson's and glaucoma, among others. - Google Patents

Compounds derived from spirocyclic acylguanidines, inhibitors of the activity of the beta-secretase enzyme (bace1); intermediary compounds; pharmaceutical composition; and use to treat a disorder or disease selected from Alzheimer's, trisomy 21 (down syndrome), senile dementia, parkinson's and glaucoma, among others.

Info

Publication number
CL2015000442A1
CL2015000442A1 CL2015000442A CL2015000442A CL2015000442A1 CL 2015000442 A1 CL2015000442 A1 CL 2015000442A1 CL 2015000442 A CL2015000442 A CL 2015000442A CL 2015000442 A CL2015000442 A CL 2015000442A CL 2015000442 A1 CL2015000442 A1 CL 2015000442A1
Authority
CL
Chile
Prior art keywords
compounds
bace1
trisomy
glaucoma
parkinson
Prior art date
Application number
CL2015000442A
Other languages
Spanish (es)
Inventor
Klaus Fuchs
Cornelia Dorner-Ciossek
Salvacion Cacatian
Deepak S Lala
Angel Morales-Ramos
Suresh B Singh
Jing Yuan
Yajun Zheng
Ruyi Bukhtiyarov
Lawrence Wayne Dillard
Ulrike Gross
Niklas Heine
Lanqi Jia
Achim Sauer
Shankar Venkatraman
Zhenrong Xu
Yi Zhao
Original Assignee
Boehringer Ingelheim Int
Vitae Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57232504&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015000442(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int, Vitae Pharmaceuticals Inc filed Critical Boehringer Ingelheim Int
Publication of CL2015000442A1 publication Critical patent/CL2015000442A1/en

Links

CL2015000442A 2013-03-15 2015-02-24 Compounds derived from spirocyclic acylguanidines, inhibitors of the activity of the beta-secretase enzyme (bace1); intermediary compounds; pharmaceutical composition; and use to treat a disorder or disease selected from Alzheimer's, trisomy 21 (down syndrome), senile dementia, parkinson's and glaucoma, among others. CL2015000442A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361788839P 2013-03-15 2013-03-15
US201361816458P 2013-04-26 2013-04-26
US201361693512P 2013-08-27 2013-08-27

Publications (1)

Publication Number Publication Date
CL2015000442A1 true CL2015000442A1 (en) 2015-06-19

Family

ID=57232504

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015000442A CL2015000442A1 (en) 2013-03-15 2015-02-24 Compounds derived from spirocyclic acylguanidines, inhibitors of the activity of the beta-secretase enzyme (bace1); intermediary compounds; pharmaceutical composition; and use to treat a disorder or disease selected from Alzheimer's, trisomy 21 (down syndrome), senile dementia, parkinson's and glaucoma, among others.

Country Status (1)

Country Link
CL (1) CL2015000442A1 (en)

Similar Documents

Publication Publication Date Title
PH12016501813A1 (en) 1,3-benzodioxole derivative
CL2013003372A1 (en) Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes.
CL2016001895A1 (en) Compounds
BR112014020826A2 (en) modulators and methods of use
WO2016066744A3 (en) Gip agonist compounds and methods
CL2016002072A1 (en) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
CL2014002757A1 (en) Compounds derived from benzamide to inhibit the activity of abl1, abl2 and bcr-abl1, pharmaceutical composition; and use in the treatment of cancer.
CL2014002334A1 (en) Compounds derived from spirulous indanes, beta-secretase inhibitors; pharmaceutical composition; and use in the treatment of diseases such as cognitive impairment, neurodegenerative disorders, dementia, among others.
CL2015001599A1 (en) Compounds derived from (pyridin or pyrimidin) - (substituted piperidine or piperazine) or their salts, cholesterol inhibitors 24-hydroxylase (ch24h); medicine; ch24h inhibition method; method to prevent or treat; and use for the prevention or treatment of epilepsy, Alzheimer's and Parkinson's, among other diseases.
BR112015022191A8 (en) heteroaryl compounds and uses thereof
CL2015000096A1 (en) Compounds derived from 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta [a] naphthalenes, phosphodiestearase 2 and / or 10 inhibitors; pharmaceutical composition; and its use for prevention or treatment of diseases of the nervous system, such as cognitive deficiency, dementia, anxiety disorders, enf. from Alzheimer, enf. from parkinson, others
WO2015067715A3 (en) Gip-glp-1 dual agonist compounds and methods
CL2012003604A1 (en) Heterocyclic compounds derived from substituted pyridine carboxamide; Preparation process; pharmaceutical composition; pharmaceutical combination; use in the treatment of cell proliferative disorders, parkinson's disease, cancer, among others.
EA201690881A1 (en) COMPOUNDS INHIBITORS AUTOTAXIN
DK2970216T3 (en) Biarylamide compounds as kinase inhibitors
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
CL2013002341A1 (en) Compounds derived from 6-cyclobutyl-1,5-dihydro-pyrazolo [3,4 d] pyrimidin-4-one, pde9a inhibitors; pharmaceutical composition; and its use for the treatment of a disease or condition related to cognitive impairment, Alzheimer's disease, vascular dementia, among others
CL2013001947A1 (en) Pharmaceutical composition comprising pioglitazone; use of pioglitazone to treat Alzheimer's; composition comprising pioglitazone.
PH12017501095A1 (en) Piperidine derivatives as hdac1/2 inhibitors
BR112015029090A2 (en) 3,4-dihydroisoquinolin-2 (1h) -yl compounds
EA201391033A1 (en) BACE-2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS
CL2014001060A1 (en) Compounds derived from aryl quinoline; obtaining process; pharmaceutical composition that includes them and use in the treatment or prophylaxis of type 2 diabetes, atherosclerosis, cancer, among other diseases.
CL2016002510A1 (en) 2-amino-6-methyl-4,4a, 5,6-tetrahydropyran [3,4-d] [1,3] thiazin-8a (8h) -yl-1,3-thiazol-4-ylamides.
WO2015015378A3 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
IL247704A0 (en) Amide compounds, methods for preparation, and use thereof as agents for the treatment and prevention of diseases caused by rna- and/or dna-containing viruses, and concomitant diseases